The effect of birth weight on clottable and intact fibrinogen levels: A twin study

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 6, 2005, Pages 1143-1148

  Tuya, Chuluuntulga ^a   Mutch, W J ^a   Broom, I ^a   McNeill, G ^b  

^a NHS GRAMPIAN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Birth weight; Fibrinogen; Twins

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; FIBRINOGEN BLOOD LEVEL; GENETIC ASSOCIATION; HUMAN; LOW BIRTH WEIGHT; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; CASE CONTROL STUDY; FACTUAL DATABASE; GENETIC PREDISPOSITION; MIDDLE AGED; STATISTICAL MODEL; THROMBOPHILIA; TWINS;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; THROMBOPHILIA; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 24944456003     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01431.x     Document Type: Article

References (35)

1. Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995; 16: 34-5.
2. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998; 19: A53-61.
3. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-6.
4. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311: 171-4.
5. Barker DJP. Mothers, Babies and Health in Later Life. Edinburgh: Churchill Livingstone, 1998.
6. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early growth, adult income, and risk of stroke. Stroke 2000; 31: 869-74.
7. Barker DJ, Lackland DT. Prenatal influences on stroke mortality in England and Wales. Stroke 2003; 34: 1598-602.
8. Martyn CN, Meade TW, Stirling Y, Barker DJ. Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intrauterine growth. Br J Haematol 1995; 89: 142-6.
9. Barker DJP, Meade TW, Fall CHD, Lee A, Osmond C, Phipps K, Stirling Y. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304: 148-52.
10. Fall CHD, Osmond C, Barker DJP, Clark PM, Hales CN, Stirling Y, Meade TW. Fetal and infant growth and cardiovascular risk factors in women. BMJ 1995; 310: 428-32.
11. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birth weight, body-mass index in middle age, and incident CHD. Lancet 1996; 348: 1478-80.
12. Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, Collin D, Czernichow P. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ 1997; 315: 341-7.
13. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Bleker OP. Plasma lipid profiles in adults after prenatal exposure to the Dutch famine. Am J Clin Nutr 2000; 72: 1101-6.
14. Morley R, Harland PSEG, Law CM, Lucas A. Birthweight and social deprivation: influences on serum lipids and fibrinogen. Acta Paediatr 2000; 89: 703-7.
15. Cook DG, Whincup PH, Miller G, Carey IM, Adshead FJ, Papacosta O, Walker M, Howarth D. Fibrinogen and factor VII levels are related to adiposity but not to fetal growth or social class in children aged 10-11 years. Am J Epidemiol 1999; 150: 727-36.
16. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet 2001; 357: 101-5.
17. Bo S, Cavallo-Perin P, Scaglione L, Pagano G. Lack of association of fibrinogen, lipoprotein(a), and albumin excretion rate with low birthweight. Int J Clin Lab Res 2000; 30: 203-5.
18. Ijzerman RG, Stehouwer CD, de Geus EJ, Kluft C, Boomsma DI. The association between birth weight and plasma fibrinogen is abolished after the elimination of genetic influences. J Thromb Haemost 2003; 1: 239-42.
19. McNeill G, Tuya C, Campbell DM, Haggarty P, Smith WC, Masson LF, Cumming A, Broom I, Haites N. Blood pressure in relation to birth weight in twins and singleton controls matched for gestational age. Am J Epidemiol 2003; 158: 150-5.
20. Tuya C, Mutch W, Broom J, Campbell DM, McNeill G. Size at birth, fasting glucose and insulin levels and insulin resistance in adult twins. Twin Res 2003; 6: 302-6.
21. Ernst E. Oral contraceptives, fibrinogen and cardiovascular risk. Atherosclerosis 1992; 93: 1-5, Review.
22. Smith WCS, Tunstall-Pedoe H, Crombie IK, Tavendale R. Concomitants of excess coronary deaths - major risk factor and lifestyle findings from 10359 men and women in Scottish Heart Health Study. Scot Med J 1989; 34: 550-5.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
24. 'Guidelines on fibrinogen assays', The British Committee for Standards in Haematology, 2002. http://www.bcshguidelines.com/.
25. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PF, Muller JE, D'Agostino RB Sr. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102: 1634-8.
26. Seifried E, Oethinger M, Tanswell P, Hoegee_de Nobel H, Nieuwenhuizen W. Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination. Blood Coagul Fibrinolysis 1992; 3: 81-7.
27. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318: 427-31.
28. Henry JA, Bolla M, Osmond C, Fall C, Barker DJ, Humphries SE. The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive. J Med Genet 1997; 34: 553-8.
29. Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP. Determinants of plasma levels of plasminogen activator inhibitor-1: a study of normotensive twins. Arteriosder Thromb Vasc Biol 1999; 19: 316-20.
30. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII, factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
31. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone WH, Blangero J, Fontcuberto J. Genetic determinants of haemostasis phenotypes in Spanish families. Circulation 2000; 101: 1546-51.
32. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RAS. Functional analysis of the fibrinogen A Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107: 2326-30.
33. Ariens RAS, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The Factor XIII Va134leu polymorphism accelerates thrombin activation of Factor XIII, and affects cross-linked fibrin structure. Blood 2000; 96: 988-95.
34. Lim BCB, Ariens RAS, Carter AM, Weisel JW, Grant PJ. Genetic regulation of fibrin structure and function: complex gene environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-31.
35. Dunn EJ, Ariens RA, de Lange M, Snieder H, Turney JH, Spector TD, Grant PJ. Genetics of fibrin clot structure: a twin study. Blood 2004; 103: 1735-40.